Press release
CD48 Antibody Market to Grow to USD 3.2 Billion by 2034, Driven by 9% CAGR on Rising Hematological
The CD48 antibody market, valued at approximately $1.3 billion in 2024, is projected to reach $3.2 billion by 2034, reflecting a robust CAGR of 9% during the forecast period. The rising incidence of hematological malignancies and autoimmune disorders is propelling demand for targeted therapies utilizing CD48 antibodies.Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of CD48 Antibody market goods. The market study excludes key regions that are accelerating marketization. This section also gives the extent of different market segments and applications that could have an impact on the market in the future. Current trends and historical turning points form the basis of the enormous amount of data. The report includes information on market trends and development, growth drivers, emerging technologies, and the investment structure of the CD48 Antibody market.
This report is also available in the following languages : Japanese (CD48抗体), Korean (CD48 항체), Chinese (CD48抗体), French (Anticorps CD48), German (CD48-Antikörper), and Italian (Anticorpo CD48), etc.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/66231
Key Companies:
AbbVie Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Johnson & Johnson, Amgen Inc., Genentech, Inc. (Roche), Gilead Sciences, Inc., AstraZeneca PLC, Sanofi S.A., Novartis AG, Regeneron Pharmaceuticals, Inc., Pfizer Inc., Takeda Pharmaceutical Company Ltd., EMD Serono (Merck KGaA), ImmunoGen, Inc.
Market Segmentation
By Product Type
Monoclonal Antibodies
Polyclonal Antibodies
By Application
Immunotherapy
Diagnostics
Research
By End User
Biopharmaceutical Companies
Academic and Research Institutes
By Technology
ELISA
Western Blotting
Flow Cytometry
By Distribution Channel
Direct Sales
Distributors
Explore Full Report here: https://exactitudeconsultancy.com/reports/66231/cd48-antibody-market
If opting for the Global version of CD48 Antibody Market; then the below country analysis would be included:
- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland, and the Rest of Europe)
- Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia, and the Rest of APAC)
- South America (Brazil, Argentina, Chile, Colombia, the Rest of the countries, etc.)
- the Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)
Buy Now @ https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=66231
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the CD48 Antibody market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the CD48 Antibody market.
Get Your Exclusive Offer with up to 30% Discount : https://exactitudeconsultancy.com/check-discount/66231
Reasons To Buy The CD48 Antibody Market Report:
➼ In-depth analysis of the market on the global and regional levels.
➼ Major changes in market dynamics and competitive landscape.
➼ Segmentation on the basis of type, application, geography, and others.
➼ Historical and future market research in terms of size, share growth, volume, and sales.
➼ Major changes and assessment in market dynamics and developments.
➼ Emerging key segments and regions
➼ Key business strategies by major market players and their key methods
Our team is available 24/7 to assist and support our customers through reliable research.
Customization
-20% free customization.
-Five Countries can be added as per your choice.
-Five Companies can added as per your choice.
-Free customization up to 40 hours.
-Post-sales support for 1 year from the date of delivery.
Other Reports:
Peritoneal Cancer Treatment Market
https://exactitudeconsultancy.com/reports/65592/peritoneal-cancer-treatment-market
Fluorescence Endoscopy System Market
https://exactitudeconsultancy.com/reports/65632/fluorescence-endoscopy-system-market
Silica Supplement Market
https://exactitudeconsultancy.com/reports/65672/silica-supplement-market
Reusable Laryngoscope System Market
https://exactitudeconsultancy.com/reports/65712/reusable-laryngoscope-system-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release CD48 Antibody Market to Grow to USD 3.2 Billion by 2034, Driven by 9% CAGR on Rising Hematological here
News-ID: 4054651 • Views: …
More Releases from Exactitude Consultancy

Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at …
Introduction
Cell therapy has emerged as a transformative pillar of modern medicine, offering the potential to repair, replace, or regenerate damaged tissues and organs. From CAR-T cell therapies for oncology to stem cell therapies for regenerative medicine, the field is redefining treatment paradigms across oncology, neurology, cardiology, and rare diseases.
As clinical pipelines expand and more therapies achieve regulatory approval, demand for efficient and scalable cell therapy manufacturing has surged. Specialized technologies…

Despite safety concerns, adavosertib exhibits early antitumor activity in uterin …
Uterine serous carcinoma (USC) is a rare but highly aggressive subtype of endometrial cancer, accounting for less than 10% of endometrial cancer cases but contributing to a disproportionately high mortality rate. It is often diagnosed at advanced stages, making it difficult to treat with conventional methods.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72873
In recent years, the treatment landscape has expanded beyond chemotherapy and surgery to include targeted therapies,…

Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Imp …
Catheter-related bloodstream infections (CRBSIs) are among the most common and serious complications associated with intravascular catheters used in hospitals and long-term care settings. These infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. With the rising use of central venous catheters, particularly among critically ill patients, oncology cases, and those requiring long-term intravenous therapy, the global demand for effective prevention and treatment solutions is growing…

ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
Introduction
Antibody-drug conjugates (ADCs) represent one of the most innovative breakthroughs in oncology, combining the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. By delivering highly toxic payloads directly to cancer cells, ADCs minimize systemic toxicity and enhance therapeutic efficacy.
As cancer incidence rises worldwide and the limitations of conventional chemotherapy become more evident, ADC technology is gaining momentum. With advancements in linker chemistry, payload design, and next-generation…
More Releases for CD48
Telematics and Vehicle Electronics Market Segmentation: Identifying Key Segments …
As of 2024, the global telematics and vehicle electronics market is valued at approximately $50 billion, driven by the growing demand for connected vehicles and advanced driver-assistance systems (ADAS). The market is expected to experience robust growth, with a projected value reaching around $85 billion by 2034. This trajectory represents a Compound Annual Growth Rate (CAGR) of approximately 5.3% over the forecast period from 2025 to 2034.
Exactitude Consultancy., Ltd. released…
Adoptive Cell Therapy Market Set to Transform Oncology and Beyond
The global adoptive cell therapy market is entering a transformative era, driven by pioneering scientific breakthroughs, growing investment, and expanding clinical applications. Adoptive cell therapies-where patients' own or donor immune cells are engineered to target disease-are redefining treatment paradigms in oncology, infectious diseases, and autoimmune disorders. The global adoptive cell therapy market was valued at approximately USD 5.1 billion in 2023 and is anticipated to reach USD 21.6 billion by…
Parkinson's Disease Treatment Market Set to Surge with Innovative Therapies and …
The global Parkinson's disease treatment market is experiencing a transformative phase, driven by relentless research breakthroughs, expanding patient awareness, and increasing investment in neurological healthcare. Parkinson's disease (PD), a progressive neurodegenerative disorder characterized by tremors, rigidity, and bradykinesia, affects nearly 10 million people worldwide. As the burden of PD intensifies, stakeholders across the healthcare continuum are rallying to bring forth cutting-edge therapies and support systems that promise to improve patient…
Tower Fan Heaters Market Set to Redefine Indoor Climate Solutions
The global heating and cooling market is undergoing significant transformation as consumers increasingly seek versatile, energy-efficient, and space-saving solutions for indoor comfort. Among the emerging segments, the tower fan heaters market is rapidly gaining momentum by combining the benefits of fan-based air distribution with the efficiency of modern heating technologies. This industry provides a comprehensive analysis of the tower fan heaters market, highlighting emerging trends, detailed industry insights, segmentation opportunities,…
Ultra High Purity Sulfuric Acid Market: Forging the Future of Industrial Excelle …
The ultra high purity sulfuric acid (UHPSA) market is rapidly emerging as a vital cornerstone in high-technology and specialty chemical industries. This market is characterized by a stringent demand for materials that exhibit exceptional purity and reliability, making UHPSA indispensable in advanced manufacturing processes, energy production, and environmental management. As global industries face increasing challenges in quality control and sustainable production, UHPSA is set to become a game changer, driving…
Transforming the Future of Metalworking: A Deep Dive into the Global Carbide Too …
This industries worldwide pursue increased precision, productivity, and durability in manufacturing, the global carbide tools market is undergoing a transformative phase. This evolution is driven by technological advancements, rising demand in various end-use industries, and the strategic expansion of market players. Today's market dynamics are not only redefining traditional machining operations but also paving the way for innovations that set new standards in performance and reliability.
Get a free sample report:…